IL89102A0 - Vectors,compounds and methods for expression of a human adenocarcinoma antigen - Google Patents

Vectors,compounds and methods for expression of a human adenocarcinoma antigen

Info

Publication number
IL89102A0
IL89102A0 IL89102A IL8910289A IL89102A0 IL 89102 A0 IL89102 A0 IL 89102A0 IL 89102 A IL89102 A IL 89102A IL 8910289 A IL8910289 A IL 8910289A IL 89102 A0 IL89102 A0 IL 89102A0
Authority
IL
Israel
Prior art keywords
vectors
expression
compounds
methods
human adenocarcinoma
Prior art date
Application number
IL89102A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL89102A0 publication Critical patent/IL89102A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL89102A 1988-01-29 1989-01-27 Vectors,compounds and methods for expression of a human adenocarcinoma antigen IL89102A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15025288A 1988-01-29 1988-01-29
US18456988A 1988-04-21 1988-04-21

Publications (1)

Publication Number Publication Date
IL89102A0 true IL89102A0 (en) 1989-08-15

Family

ID=26847467

Family Applications (1)

Application Number Title Priority Date Filing Date
IL89102A IL89102A0 (en) 1988-01-29 1989-01-27 Vectors,compounds and methods for expression of a human adenocarcinoma antigen

Country Status (7)

Country Link
US (1) US5348887A (fr)
EP (1) EP0326423B1 (fr)
JP (1) JP2774298B2 (fr)
CA (1) CA1340221C (fr)
DE (1) DE68922757T2 (fr)
DK (1) DK35189A (fr)
IL (1) IL89102A0 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU643189B2 (en) 1988-09-06 1993-11-11 Xoma Corporation Production of chimeric mouse-human antibodies with specificity to human tumor antigens
US20050196400A1 (en) * 1991-05-06 2005-09-08 Xoma Technology Ltd. Production of chimeric mouse-human antibodies with specificity to human tumor antigens
WO1993008298A1 (fr) * 1991-10-18 1993-04-29 The Wistar Institute Of Anatomy And Biology Variants solubles des proteines de membrane de type i, et procedes d'utilisation de ceux-ci
EP0857176A1 (fr) * 1995-10-25 1998-08-12 Centocor B.V. PEPTIDES DERIVES DE L'Ep-CAM ANTIGENE EPITHELIAL HUMAIN ET LEUR EMPLOI
EP1378525A3 (fr) * 1996-06-07 2004-01-14 Neorx Corporation Anticorps humanisés qui se lient à l'antigène relié par l'anticorp NR-LU-13 et leur utilisation dans des méthodes de ciblage
JP4540033B2 (ja) 1999-10-22 2010-09-08 サノフィ パストゥール リミテッド 腫瘍抗原に対する免疫応答を誘発および／または増強する方法
US20020177552A1 (en) * 2000-06-09 2002-11-28 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
AU2002364161A1 (en) * 2001-12-12 2003-06-23 Aventis Pasteur Limited Enhancement of the immune response using cd36-binding domain
US6747123B2 (en) * 2002-03-15 2004-06-08 Lucent Technologies Inc. Organosilicate materials with mesoscopic structures
AU2003223527B2 (en) 2002-04-09 2009-01-15 Sanofi Pasteur Limited Modified CEA nucleic acid and expression vectors
US20050084913A1 (en) * 2003-04-22 2005-04-21 Maxygen, Inc. Novel tumor-associated antigens
CN101124327A (zh) * 2003-10-08 2008-02-13 圣诺菲·帕斯图尔公司 经修饰的cea/b7载体
US20090156519A1 (en) * 2003-12-23 2009-06-18 Aventis Pasteur, Inc. Modified KSA and Uses Thereof
JP5779352B2 (ja) 2008-03-14 2015-09-16 サノフィ パスツール バイオロジクス リミテッド ライアビリティ カンパニー 複製欠損フラビウイルスワクチンおよびワクチンベクター
WO2014140938A2 (fr) 2013-03-14 2014-09-18 Centre Hospitalier Universitaire Vaudois Méthodes immunologiques

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76877A (en) * 1984-11-02 1991-11-21 Oncogen Diagnostic method for the determination of human non-small cell lung carcinomas employing novel monoclonal antibodies and compositions containing said antibodies
EP0246709A1 (fr) * 1986-05-20 1987-11-25 Stichting Katholieke Universiteit ADN recombinant et ADN complémentaire, ARN messager, protéine, anticorps et méthode de détection de cellules tumorales

Also Published As

Publication number Publication date
EP0326423B1 (fr) 1995-05-24
JPH025867A (ja) 1990-01-10
DK35189A (da) 1989-07-31
EP0326423A3 (en) 1989-10-18
JP2774298B2 (ja) 1998-07-09
CA1340221C (fr) 1998-12-15
DE68922757D1 (de) 1995-06-29
US5348887A (en) 1994-09-20
DE68922757T2 (de) 1995-11-16
EP0326423A2 (fr) 1989-08-02
DK35189D0 (da) 1989-01-27

Similar Documents

Publication Publication Date Title
IL90016A0 (en) Novel recombinant and chimeric antibodies directed against a human adenocarcinoma antigen
IL89489A0 (en) Chimeric antibodies directed against human carcinoembryonic antigen
GB8913067D0 (en) Multiple-set packer and method
IL89102A0 (en) Vectors,compounds and methods for expression of a human adenocarcinoma antigen
IL101507A0 (en) Compounds,vectors and methods for expressing human,cytosolic phospholipase a2
EP0337183A3 (en) Method of shaping natural leather
IL85955A0 (en) Human tumor-associated antigen
GB8801936D0 (en) Explosives devices & methods of use thereof
GB2221147B (en) Handbag
PL280010A1 (en) Method of obtaining a pseudopyrimicine complex
PL276098A1 (en) Method of obtaining 2,3-dibromide-2-butene-1,4-diole
ZA894492B (en) Exploration method
GB8830404D0 (en) Method of forming a bag
IE881054L (en) Human monoclonal antibodies determinants of gram negative¹bacteria
MW6789A1 (en) Process for preparations emulsion explosives
PL276128A1 (en) Method of obtaining pigmentous preparations
PL276127A1 (en) Method of obtaining pigmentous preparations
PL276130A1 (en) Method of obtaining pigmentous preparations
PL276129A1 (en) Method of obtaining pigemnous preparations
PL276132A1 (en) Method of obtaining pigmentous preparations
PL276125A1 (en) Method of obtaining pigmentous preparations
PL276131A1 (en) Method of obtaining pigmentous preparations
PL276126A1 (en) Method of obtaining pigementous preparations
GB8809874D0 (en) Method of bag closure
ZA894169B (en) Method of manufacturing carry bags